Detalhe da pesquisa
1.
Odilorhabdins, Antibacterial Agents that Cause Miscoding by Binding at a New Ribosomal Site.
Mol Cell
; 70(1): 83-94.e7, 2018 04 05.
Artigo
Inglês
| MEDLINE | ID: mdl-29625040
2.
Missense Mutations in the CrrB Protein Mediate Odilorhabdin Derivative Resistance in Klebsiella pneumoniae.
Antimicrob Agents Chemother
; 65(5)2023 05 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33685902
3.
Exploring Cluster-Dependent Antibacterial Activities and Resistance Pathways of NOSO-502 and Colistin against Enterobacter cloacae Complex Species.
Antimicrob Agents Chemother
; 66(11): e0077622, 2022 11 15.
Artigo
Inglês
| MEDLINE | ID: mdl-36200761
4.
Structure-activity relationship studies on the inhibition of the bacterial translation of novel Odilorhabdins analogues.
Bioorg Med Chem
; 28(11): 115469, 2020 06 01.
Artigo
Inglês
| MEDLINE | ID: mdl-32279921
5.
In Vitro and In Vivo Characterization of NOSO-502, a Novel Inhibitor of Bacterial Translation.
Antimicrob Agents Chemother
; 62(9)2018 09.
Artigo
Inglês
| MEDLINE | ID: mdl-29987155
6.
Total Synthesis and Structure-Activity Relationships Study of Odilorhabdins, a New Class of Peptides Showing Potent Antibacterial Activity.
J Med Chem
; 61(17): 7814-7826, 2018 09 13.
Artigo
Inglês
| MEDLINE | ID: mdl-30086230